XML 67 R44.htm IDEA: XBRL DOCUMENT v3.20.4
SHAREHOLDERS' EQUITY (Share Option Plans) (Narrative) (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Apr. 14, 2020
shares
Oct. 10, 2018
USD ($)
$ / shares
Jun. 14, 2018
USD ($)
$ / shares
shares
Mar. 16, 2020
$ / shares
shares
May 25, 2018
USD ($)
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
Dec. 31, 2020
₪ / shares
Dec. 31, 2019
₪ / shares
May 25, 2018
₪ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Weighted average fair value of stock options granted | $ / shares           $ 7.15 $ 1.73 $ 1.56      
Unrecognized share-based compensation expense           $ 11,236          
Unrecognized compensation cost, recognition period           3 years 4 months 24 days          
Ordinary shares, par value | ₪ / shares                 ₪ 0.01 ₪ 0.01  
Ordinary shares, shares authorized | shares           200,000,000 200,000,000        
Proceeds from warrant exercised           $ 18,325      
Equity investment           12,000          
Deferred participation of BMS in R&D expenses           $ 4,121          
Employee Stock Purchase Plan [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Ordinary shares reserved for issuance | shares           600,000          
Ordinary shares available for issuance | shares           600,000          
Offering period           five months          
Percentage of use of base salary to purchase ordinary shares           15.00%          
Aggregate limit of ordinary shares per calendar year | $ / shares           $ 40          
Percentage of fair market value of ordinary shares at time of offering           85.00%          
Director [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Aggregate intrinsic value of exercised options           $ 21,610 979 $ 1,521      
2000 and 2010 Share Option Plans [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Ordinary shares reserved for issuance | shares           12,395,152          
Ordinary shares available for issuance | shares           2,366,351          
Vesting period           4 years          
Award expiration period           10 years          
Warrant [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Ordinary shares, shares authorized | shares           3,866,139          
Warrants purchase to ordinary shares remain outstanding | shares           387,026          
Proceeds from warrant exercised           $ 18,325          
At The Market Offering Program [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Ordinary shares, par value | ₪ / shares                     ₪ 0.01
Proceeds from issuance of common stock         $ 25,000   $ 22,914        
Issuance of shares, net, shares | shares             7,245,268        
Issuance expenses             $ 781        
Agreement [Member] | Registered direct offering [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Offering price per share | $ / shares     $ 3.95                
Proceeds from issuance of common stock     $ 19,767                
Ordinary shares, shares authorized | shares     5,316,457                
Warrants purchase to ordinary shares | shares     4,253,165                
Exercise price of warrants | $ / shares     $ 4.74                
Expiration period of warrants     5 years                
Issuance expenses     $ 1,233                
Master Clinical Agreement [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Offering price per share | $ / shares   $ 4.95                  
Proceeds from issuance of common stock   $ 2,424,243                  
Equity investment   $ 12,000                  
Percentage of closing price   33.00%                  
Collaborative Arrangements [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Proceeds from issuance of common stock           7,788          
Issuance expenses           $ 91          
SVB Leerink LLC and Stifel, Nicolaus & Company [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Offering price per share | $ / shares       $ 9.00              
Issuance of shares, net, shares | shares       8,333,334   8,816,339          
Issuance expenses           $ 5,200          
Proceeds from ordinary shares in offering           $ 74,147          
SVB Leerink LLC and Stifel, Nicolaus & Company [Member] | Underwriters [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Offering price per share | $ / shares       $ 8.46              
Issuance of shares, net, shares | shares 483,005